Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4zme | ADN | Myosin heavy chain kinase A | 2.7.11.7 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4zme | ADN | Myosin heavy chain kinase A | 2.7.11.7 | 1.000 | |
4zs4 | ATP | Myosin heavy chain kinase A | 2.7.11.7 | 0.665 | |
3pdt | ADP | Myosin heavy chain kinase A | 2.7.11.7 | 0.616 | |
5e9e | ANP | Myosin heavy chain kinase A | 2.7.11.7 | 0.600 | |
3lmh | ADP | Myosin heavy chain kinase A | 2.7.11.7 | 0.597 | |
3lla | ACP | Myosin heavy chain kinase A | 2.7.11.7 | 0.551 | |
1ia9 | ANP | Transient receptor potential cation channel subfamily M member 7 | 2.7.11.1 | 0.545 | |
3lmi | ATP | Myosin heavy chain kinase A | 2.7.11.7 | 0.500 | |
2w5a | ADP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.470 | |
1iah | ADP | Transient receptor potential cation channel subfamily M member 7 | 2.7.11.1 | 0.467 | |
3d5w | ADP | Serine/threonine-protein kinase PLK | / | 0.460 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.459 | |
4fcd | 0T6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.459 | |
1rvv | INI | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.454 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.452 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.452 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.452 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
3ufl | 508 | Beta-secretase 1 | 3.4.23.46 | 0.449 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.446 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
1n71 | COA | Aac(6')-Ii protein | / | 0.442 | |
1xng | DND | NH(3)-dependent NAD(+) synthetase | 6.3.1.5 | 0.442 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
2jdd | ACO | Probable acetyltransferase | / | 0.442 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.442 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 |